Atripla and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Atripla (efavirenz; emtricitabine; tenofovir disoproxil fumarate), especially for people who are male, 40-49 old, have been taking the drug for 10+ years also take Sustiva, and have High blood pressure.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Atripla. It is created by eHealthMe based on reports of 35,479 people who have side effects when taking Atripla from the FDA, and is updated regularly.

What is Atripla?

Atripla has active ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. eHealthMe is studying from 36,036 Atripla users. Check the latest studies of Atripla.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,401 drugs and 3,354 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

35,479 people reported to have side effects when taking Atripla.
Among them, 51 people (0.14%) have Swallowing difficulty.

Could Atripla cause Swallowing difficulty?

Among these 51 people:

How long have people been on Atripla when they have Swallowing difficulty? *

What is the gender of people who have Swallowing difficulty when taking Atripla? *

female: 41.3 %
male: 58.7 %

What is the age of people who have Swallowing difficulty when taking Atripla? *

What are other drugs people take besides Atripla? *

What are other side effects people have besides Swallowing difficulty? *

Weight Decreased: 8 people, 15.69%
Weakness: 7 people, 13.73%
Chest Pain: 7 people, 13.73%
Stress And Anxiety: 6 people, 11.76%
Aortic Stenosis (obstruction to the outflow of blood from the left ventricle into the aorta): 6 people, 11.76%
Bronchial Carcinoma (lung cancer): 6 people, 11.76%
Dyspnea (difficult or laboured breathing): 6 people, 11.76%
Myopathy (a muscular disease in which the muscle fibres do not function): 6 people, 11.76%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 6 people, 11.76%
Haematuria (presence of blood in urine): 6 people, 11.76%

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 7.84%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 3.92%
High Blood Cholesterol: 2 people, 3.92%
Toxoplasmosis (a parasitic disease caused by the protozoan toxoplasma gondii): 1 person, 1.96%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 1 person, 1.96%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 1.96%
Depression: 1 person, 1.96%
Hepatitis C: 1 person, 1.96%
Mood Swings (an extreme or rapid change in mood): 1 person, 1.96%
Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 1.96%

* Approximation only. Some reports may have incomplete information.

Do you take Atripla and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atripla:

Atripla (36,036 reports)

Swallowing difficulty treatments and more:

Swallowing difficulty (112,312 reports)

How severe was Swallowing difficulty and when was it recovered:

Swallowing difficulty in Atripla

Expand to all the drugs that have ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate:

Swallowing difficulty and drugs with ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate (39 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atripla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Swallowing difficulty (2,401 drugs)

Browse all the conditions that are associated with Swallowing difficulty:

Swallowing difficulty (3,354 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on efavirenz; emtricitabine; tenofovir disoproxil fumarate (the active ingredients of Atripla) and Atripla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.